Bausch Health Reports Q1 2026 Earnings with Revenue Growth and Margin Expansion
Bausch Health (BHC) reported Q1 2026 earnings with total revenue of $2.524 billion, up 12% reported and 7% organic, driven by Salix and Solta performance. Adjusted EBITDA rose 27% year over year to $837 million, and adjusted gross margin increased by 100 basis points to 70.9%. The company also noted strong performance in Salix and international segments, though Canada saw a 7% decline in revenue.
Topics: Adjusted EBITDA Financial Results Operating Expenses Revenue Growth Segment Performance